Machine Learning Based Risk Prediction for Major Adverse Cardiovascular Events
Michael Schrempf1, Diether Kramer1, Stefanie Jauk1,2
1Steiermärkische Krankenanstaltengesellschaft m. b. H., Graz, Austria.
Insights
Machine learning models predict the 5-year risk of major adverse cardiovascular events (MACE) like heart attack and stroke. A random forest model showed excellent performance, identifying high-risk patients for early intervention.
Area of Science:
- Cardiovascular medicine
- Medical informatics
- Machine learning in healthcare
Background:
- Major adverse cardiovascular events (MACE), including myocardial infarction and stroke, lead to significant hospitalizations and mortality.
- Early identification of at-risk patients is crucial for implementing preventive interventions.
- Developing robust risk prediction tools is essential for improving patient outcomes.
Purpose of the Study:
- To develop and evaluate machine learning models for predicting the 5-year risk of MACE.
- To leverage electronic medical record data for comprehensive cardiovascular risk assessment.
- To identify key features for accurate MACE prediction.
Main Methods:
- Utilized electronic medical records from over 128,000 patients, with 29,262 diagnosed with MACE.
- Applied feature selection techniques (filter and embedded methods) to identify 826 relevant features.
- Trained and evaluated various machine learning models on the prepared dataset.
Main Results:
- A random forest model demonstrated superior calibration and discriminative ability.
- The best performing model achieved an Area Under the Receiver Operating Characteristic curve (AUROC) of 0.88 on a test dataset.
- The models showed excellent predictive performance in the evaluated test data.
Conclusions:
- The developed machine learning models exhibit excellent performance for 5-year MACE risk prediction.
- Further prospective studies are required to validate the clinical utility and benefit of these models.
- These models hold potential for early detection and prevention of cardiovascular events.
Background:
Patients with major adverse cardiovascular events (MACE) such as myocardial infarction or stroke suffer from frequent hospitalizations and have high mortality rates. By identifying patients at risk at an early stage, MACE can be prevented with the right interventions.
Objectives:
The aim of this study was to develop machine learning-based models for the 5-year risk prediction of MACE.
Methods:
The data used for modelling included electronic medical records of more than 128,000 patients including 29,262 patients with MACE. A feature selection based on filter and embedded methods resulted in 826 features for modelling. Different machine learning methods were used for modelling on the training data.
Results:
A random forest model achieved the best calibration and discriminative performance on a separate test data set with an AUROC of 0.88.
Conclusion:
The developed risk prediction models achieved an excellent performance in the test data. Future research is needed to determine the performance of these models and their clinical benefit in prospective settings.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Relative Risk
Coronary Artery Disease IV: Preventive Measures
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
